Entering text into the input field will update the search result below

Oramed nabs new patent in U.S.

  • The USPTO has allowed Oramed Pharmaceuticals' (NASDAQ:ORMP) U.S. patent for the technology "Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and using Same".
  • The protease inhibitors allow the insulin and other proteins to travel through the body intact.
  • Shares are down 1% premarket.

Recommended For You

About ORMP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ORMP--
Oramed Pharmaceuticals Inc.